Alnylam Pharmace. buy Raymond James
Summary
This prediction ended on 31.07.26 with a price of €180.25. The BUY prediction by Raymond_James for Alnylam Pharmace. performed very badly with a performance of -38.90%. Raymond_James has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Raymond_James has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | -0.279% | -0.279% | -50.089% |
| iShares Core DAX® | -1,06 % | 5,01 % | 6,60 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % | 25,79 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % | 41,31 % |
| iShares S&P 500 | -1,78 % | 1,39 % | 21,04 % |
Comments by Raymond_James for this prediction
In the thread Alnylam Pharmace. diskutieren
In the thread Trading Alnylam Pharmace.
Current prediction by Raymond_James for Alnylam Pharmace.
Alnylam Pharmace.
03.08.26
03.08.27
20.08.26
Stopped prediction by Raymond_James for Alnylam Pharmace.
Alnylam Pharmace.
01.11.24
01.11.25
02.11.25
Alnylam Pharmace.
02.08.24
02.08.25
03.08.25

